SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

Momenta Pharmaceuticals, Inc. (MNTA)

MNTA RSS Feed
Add MNTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 8/15/2017 12:11:21 PM - Followers: 176 - Board type: Free - Posts Today: 0
MNTA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MNTA News: Statement of Changes in Beneficial Ownership (4) 08/14/2017 03:00:16 PM
MNTA News: Statement of Changes in Beneficial Ownership (4) 08/14/2017 02:57:15 PM
MNTA News: Statement of Changes in Beneficial Ownership (4) 08/14/2017 02:53:17 PM
MNTA News: Securities Registration: Employee Benefit Plan (s-8) 08/07/2017 05:13:17 PM
MNTA News: Quarterly Report (10-q) 08/04/2017 04:06:03 PM
PostSubject
#17095  Sticky Note The M923 phase-3 trial has already finished, for DewDiligence 04/13/17 06:10:07 PM
#17593   I know exactly how to handicap this --- cpaok1 08/15/17 12:11:21 PM
#17592   If You Eat an Animal That Ate Drugs, jbog 08/15/17 11:18:16 AM
#17591   Somewhat O/T - floblu14 08/14/17 11:38:04 AM
#17590   IMHO - Q3 2017 little if any chance. Q4 rwwine 08/14/17 11:13:09 AM
#17589   what we have seen from the very good jbog 08/14/17 07:32:22 AM
#17588   Probability of approval this Q? alternatepatel 08/14/17 05:36:47 AM
#17587   Then how did Teva end up controlling the 10nisman 08/11/17 08:43:31 PM
#17586   you can control the market quickly by aggressive tony111 08/11/17 07:51:25 PM
#17585   6 months since the letter to Pfizer.....another 6 rwwine 08/11/17 06:05:14 PM
#17584   AMPH was too aggressive with price cutting. jbog 08/11/17 04:03:59 PM
#17583   AMPH was too aggressive with price cutting. tony111 08/11/17 02:03:54 PM
#17582   Enox has had generic competition for 7 years, DewDiligence 08/11/17 09:46:53 AM
#17581   Isn't Enox a Complex drug? I'm sure jbog 08/11/17 09:39:19 AM
#17580   Complex generics with few market entrants still produce DewDiligence 08/11/17 09:20:53 AM
#17579   And do you see a similar situation with jbog 08/11/17 07:56:46 AM
#17578   No one is making money on enoxaparin anymore. DewDiligence 08/10/17 04:36:44 PM
#17577   There has been an absolute void of discussion jbog 08/10/17 04:13:38 PM
#17576   Always the optimist Jbog... indigokid 08/10/17 04:08:02 PM
#17575   "Target action" dates for ANDAs are not the DewDiligence 08/10/17 10:30:08 AM
#17574   I have a suspicion that both Momenta and jbog 08/10/17 10:07:54 AM
#17573   Mylan sounds frustrated this time...still has a TAD. alternatepatel 08/10/17 01:11:37 AM
#17572   Teva must have the whole enoxaparin market. jbog 08/09/17 04:29:00 PM
#17571   Too bad its not a patent on cooling anotherbiotechguy 08/09/17 01:33:10 PM
#17570   flo, go click on the link you say (#3). jbog 08/09/17 12:15:42 PM
#17569   That link has a different look to it. anotherbiotechguy 08/09/17 11:43:35 AM
#17568   MYL removes Copaxone from 2017 guidance. (Source: Today’s DewDiligence 08/09/17 10:07:49 AM
#17567   CHRS update on Humira FoB: #msg-133648837. DewDiligence 08/07/17 06:08:43 PM
#17566   I haven't looked at the stock in awhile. jbog 08/07/17 05:00:12 PM
#17565   I wasn't aware of the recent cut. jbog 08/07/17 04:34:28 PM
#17564   The link has been corrected... floblu14 08/07/17 03:22:24 PM
#17563   Teva cut the dividend from .34 cents a inthegrass 08/07/17 03:16:07 PM
#17562   MNTA nemesis TEVA and other generic players like jbog 08/07/17 02:10:51 PM
#17561   Oh how the mighty have fallen! It inthegrass 08/07/17 01:55:47 PM
#17560   Cool jbog 08/07/17 12:34:43 PM
#17559   The link has been corrected and now reads: anotherbiotechguy 08/07/17 12:10:06 PM
#17558   The ATM financing facility has been used up, DewDiligence 08/06/17 04:12:08 PM
#17557   They do have almost half a billion and MadCityCyclone 08/06/17 12:24:29 PM
#17556   Two items - floblu14 08/05/17 07:29:23 PM
#17555   MNTA ReadMeFirst DewDiligence 08/04/17 05:45:12 PM
#17554   MNTA had 82.6M diluted shares for valuation purposes DewDiligence 08/04/17 05:21:47 PM
#17553   MNTA’s 6/30/17 pro forma cash balance was $464.2M—a DewDiligence 08/04/17 05:09:32 PM
#17552   Inasmuch as CW admits the earliest possible US DewDiligence 08/03/17 07:17:35 PM
#17550   If Momenta plans on Submitting Humeria this year jbog 08/03/17 07:10:59 PM
#17549   TEVA reports 2Q17 US Copaxone sales of $843M, DewDiligence 08/03/17 12:52:45 PM
#17548   Transcript of MNTA 2Q17 CC: DewDiligence 08/03/17 09:57:05 AM
#17547   MNTA 2017-2018 News Flow DewDiligence 08/02/17 05:00:04 PM
#17546   Please see #msg-133516358. DewDiligence 08/02/17 04:22:56 PM
#17545   CW said MNTA is leaning toward the M230 DewDiligence 08/02/17 04:22:15 PM
#17544   MNTA has chosen to take the 50%/50% route jbog 08/02/17 03:23:50 PM
#17543   MNTA has chosen to take the 50%/50% route inthegrass 08/02/17 09:55:51 AM
PostSubject